Evidence map›Paper›PMID 35225034›Full record

ReviewJournal of investigative medicine high impact case reports

Two Cases of Miliary and Disseminated Coccidioidomycosis Following Glucocorticoid Therapy and Literature Review.

Rowis Sous, Yuliya Levkiavska, Rupam Sharma, Roopam Jariwal, Daniela Amodio, Royce H Johnson, Arash Heidari, Rasha Kuran

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Journal of investigative medicine high impact case reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Rowis SousKern Medical, Bakersfield, CA, USA.
Yuliya LevkiavskaKern Medical, Bakersfield, CA, USA.
Rupam SharmaKern Medical, Bakersfield, CA, USA.ORCID 0000-0003-3457-4371
Roopam JariwalKern Medical, Bakersfield, CA, USA.
Daniela AmodioRio Bravo Family Medicine Residency Program, Bakersfield, CA, USA.
Royce H JohnsonKern Medical, Bakersfield, CA, USA.
Arash HeidariKern Medical, Bakersfield, CA, USA.ORCID 0000-0003-1091-348X
Rasha KuranKern Medical, Bakersfield, CA, USA.
Kern Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 49-year-old man with no significant past medical history received dexamethasone as part of his treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Less than 3 weeks later, the patient developed acute respiratory distress syndrome. Radiological and serological testing led to a diagnosis of acute hypoxic miliary coccidioidomycosis. A 52-year-old man with a past medical history of chronic kidney disease (CKD) was treated with prednisone for focal segmental glomerulosclerosis (FSGS). Within 2 weeks, this patient developed bilateral lower extremity weakness. Radiology, serology, and lumbar puncture proved a diagnosis of reactivated coccidioidomycosis with miliary pattern and coccidioidomycosis meningoencephalitis with arachnoiditis. Whether treatment with glucocorticoids caused reactivation of coccidioidomycosis is discussed in this case series.

Indexed as

CoccidioidomycosisCOVID-19 Drug TreatmentRespiratory Distress SyndromeGlucocorticoidsHumansMaleMiddle AgedSARS-CoV-2Glucocorticoidscoccidioidomycosisglucocorticoidimmunosuppressionmiliary coccidioidomycosisreactivation of coccidioidomycosis

Identifiers

PMID35225034
PMCPMC8891939
OpenAlexW4214637536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.